Expansion Therapeutics Company
Pursuing the Vast Potential of Small Molecule Medicines for RNA-Mediated Diseases.
Total Funding:
$121.5M
Headquarters:
San Diego, California, United States
Funding Status:
Early Stage Venture
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series A
Technology:
Immunotherapy
Investors Number:
6
Founded Date:
2016
Industry:
PharmTech